Scientists at Ireland-based Cosmo Pharmaceuticals have found a solution for male baldness, as per a press release by the company. It said that 1,465 patients enrolled in the trials conducted in US and Europe, that used clascoterone 5% topical solution. "One study demonstrated a 539% relative improvement in Target-Area Hair Count (TAHC) versus placebo vehicle," the company said.